Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Plos One|November 1, 2016
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical PracticePierre Gantner, Firouze Bani-Sadr, Rodolphe Garraffo, et al.
Molecular Imaging and Biology|November 17, 2020
Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in RatsDavid Rey-Bretal, Alexis Moscoso, Noemí Gómez-Lado, et al.
Antiviral Therapy|June 27, 2007
First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomesValérie Potard, David Rey, Saadia Mokhtari, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 22, 2014
A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the HajjLauren M Gardner, David Rey, Anita E Heywood, et al.
Journal of the International AIDS Society|September 28, 2014
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysisValérie Potard, David Rey, Isabelle Poizot-Martin, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
Neuroimage|May 24, 2020
White matter hyperintensities are associated with subthreshold amyloid accumulationAlexis Moscoso, David Rey-Bretal, Jesús Silva-Rodríguez, et al.
AIDS (London, England)|July 14, 2023
Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people with HIV in FranceRomain Palich, Maxime Hentzien, Laurent Hocqueloux, et al.
AIDS (London, England)|April 28, 2023
Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in FranceRomain Palich, Maxime Hentzien, Laurent Hocqueloux, et al.
AIDS (London, England)|March 14, 2020
Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57:01Maxime Hentzien, Lise Cuzin, François Raffi, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Plos One|November 1, 2016
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical PracticePierre Gantner, Firouze Bani-Sadr, Rodolphe Garraffo, et al.
Molecular Imaging and Biology|November 17, 2020
Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in RatsDavid Rey-Bretal, Alexis Moscoso, Noemí Gómez-Lado, et al.
Antiviral Therapy|June 27, 2007
First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomesValérie Potard, David Rey, Saadia Mokhtari, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 22, 2014
A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the HajjLauren M Gardner, David Rey, Anita E Heywood, et al.
Journal of the International AIDS Society|September 28, 2014
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysisValérie Potard, David Rey, Isabelle Poizot-Martin, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
Neuroimage|May 24, 2020
White matter hyperintensities are associated with subthreshold amyloid accumulationAlexis Moscoso, David Rey-Bretal, Jesús Silva-Rodríguez, et al.
AIDS (London, England)|July 14, 2023
Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people with HIV in FranceRomain Palich, Maxime Hentzien, Laurent Hocqueloux, et al.
AIDS (London, England)|April 28, 2023
Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in FranceRomain Palich, Maxime Hentzien, Laurent Hocqueloux, et al.
AIDS (London, England)|March 14, 2020
Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57:01Maxime Hentzien, Lise Cuzin, François Raffi, et al.
Pageof 11